We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
AusPAR: Mogamulizumab
Australian Public Assessment Report
Device/Product Name
Poteligeo
Active ingredients
Mogamulizumab
AusPAR Date
Published
Sponsor
Submission Number
PM-2020-00700-1-6
Submission Type
New biological entity
Decision
Approved